The Central Drugs standard control organisation vide Notification dated 26th November 2019 has directed every state drug controller to initiate steps for strengthening public health by sensitizing and to advice every clinicians and other healthcare professional to mandatorily report about medical devices adverse event to Materiovigilance Programme of India (“MvpPI”) MvPI-IPC
Materiovigilance Programme of India aims to improve patient safety and welfare of the Indian population by monitoring medical devices’ safety and thereby reducing the risks associated with the use of medical devices. Such monitoring will help in assessing, monitoring and detecting adverse effects of medical devices, their malfunctions etc. that can result in higher morbidity and mortality.
Therefore Healthcare professionals need to be well informed about the adverse effects of medical devices by developing educational and promotional interventions like continuous medical education, awareness program, workshops, conferences on materiovigilance etc.
Click here to read the Notification.
